Jeffrey Crittenden, MD
Gastroenterology · Dothan, ALNPI 1043264336
Payments from drug & device makers
Across 441 payments — averaging $595.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$256K
- AbbVie$2K
- Johnson & Johnson$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$465
- Bristol Myers Squibb$349
- Ironwood Pharmaceuticals, Inc$334
- plus $2K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 68 | $256,472 |
| AbbVie(2 entities) | 110 | $1,913 |
| Johnson & Johnson | 101 | $1,265 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $465 |
| Bristol Myers Squibb | 21 | $349 |
| Ironwood Pharmaceuticals, Inc | 25 | $334 |
| Sanofi | 13 | $329 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $296 |
| Janssen Scientific Affairs, LLC | 2 | $236 |
| Nestle Healthcare Nutrition Inc. | 10 | $189 |
| Ferring Pharmaceuticals Inc. | 8 | $129 |
| Olympus America Inc. | 2 | $127 |
| Regeneron Healthcare Solutions, Inc. | 5 | $72 |
| Pfizer | 4 | $72 |
| Boston Scientific | 1 | $64 |
| Merck | 3 | $63 |
| Medtronic | 3 | $58 |
| Lilly USA, LLC | 3 | $50 |
| Intercept Pharmaceuticals, Inc. | 3 | $50 |
| Braintree Laboratories, Inc. | 3 | $47 |
| Ardelyx, Inc. | 2 | $41 |
| Madrigal Pharmaceuticals | 2 | $39 |
| Portola Pharmaceuticals, LLC | 1 | $35 |
| Evoke Pharma, Inc. | 2 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 2 | $28 |
| Fresenius Kabi USA, LLC | 1 | $17 |
| AstraZeneca | 1 | $14 |
How this compares
$262,815 in reported general payments places this provider in the 90th percentile of 225 gastroenterology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Dothan
- Paul LambDothan$1.2M
- William McLaughlinDothan$745K
- Samuel TarwaterDothan$664K
- Travis RutlandDothan$552K
- George NelsonDothan$300K
- Robert AlbaresDothan$97K
- Scott SarrelsDothan$77K
- Jonathan SiegelMobile$2.6M
- Michael BrownDecatur$1.7M
- Robert ShafferBirmingham$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.